159017-89-7

Usage

Uses

Used in Fragrance and Flavor Industry:
(E)-4-isopropoxycinnamaldehyde is used as a key component in the creation of perfumes, soaps, and other cosmetic products, leveraging its distinct floral, green, and woody scent to enhance the overall aroma and appeal of these products.
Used in Pharmaceutical Applications:
(E)-4-isopropoxycinnamaldehyde is explored for its potential pharmaceutical uses, particularly due to its antimicrobial and anti-inflammatory properties. These characteristics make it a candidate for the development of new treatments and therapies in the medical field.
Used as a Food Additive:
(E)-4-isopropoxycinnamaldehyde has been investigated for its potential use as an additive in the food industry, where it could be utilized to enhance flavors and provide a unique taste experience for consumers.
Used in Agricultural Applications:
(E)-4-isopropoxycinnamaldehyde's potential in agriculture is also being studied, possibly for its application in enhancing the quality or characteristics of certain crops or for use in pest control or other agricultural practices.

Upstream product

• 159017-88-6 (E)-3-(4-isopropoxyphenyl)-2-propen-1-ol 

Downstream Products

• 159017-90-0 5-[3-(4-hydroxy-phenyl)-propyl]-oxazolidine-2,4-dione 
• 178238-92-1 5-[3-(4-hydroxy-phenyl)-propyl]-thiazolidine-2,4-dione 
• 178238-49-8 5-[3-(4-isopropoxyphenyl)propyl]-2,4-thiazolidinedione 
• 159017-18-2 5-[3-(4-isopropoxy-phenyl)-propyl]-oxazolidine-2,4-dione 
• 159017-03-5 5-[3-[4-[(5-Methyl-2-phenyl-4-thiazolyl)methoxy]-phenyl]propyl]-2,4-oxazolidinedione 
• 330574-43-1 (R)-(+)-5-[3-[4-(5-methyl-2-phenyl-4-thiazolylmethoxy)phenyl]propyl]-2,4-oxazolidinedione 
• 586960-19-2 5-(4-Isopropyloxy phenyl)-2E, 4E-pentadienoic Acid 

Relevant academic research and scientific papers

Novel substituted aryl alkenoic acid heterocyclic amides

The present invention relates to novel compounds possessing specific hot, pungent and spicy taste when subjected to direct pungency evaluation, which may be useful as food additives and anti-oxidants, however the said compounds do not add to any nutrition

Novel 5-substituted 2,4-thiazolidinedione and 2,4-oxazolidinedione derivatives as insulin sensitizers with antidiabetic activities

Two novel classes of 2,4-thiazolidinediones and 2,4-oxazolidinediones with an ω-(azolylalkoxyphenyl)alkyl substituent at the 5-position were prepared and their antidiabetic effects were evaluated in two genetically obese and diabetic animal models, KKAy mice and Wistar fatty rats. A large number of the 2,4-thia(oxa)zolidinediones showed potent glucose- and lipid-lowering activities. The antidiabetic activities of the 2,4-oxazolidinediones were superior to those of the 2,4-thiazolidinediones. Among the compounds, both enantiomers of 5-[3-[4-[2-(2-furyl)-5-methyl-4-oxazolylmethoxy]-3- methoxyphenyl]propyl]-2,4-oxazolidinedione (64), one of the most interesting compounds in terms of activity, were synthesized by using an asymmetric O-acetylation of the corresponding α-hydroxyvalerate (26) with immobilized lipase, followed by cyclization of the oxazolidinedione ring. (R)-(+)-64 showed more potent glucose-lowering activity (effective dose (ED)25 = 0.561 mg/kg/d) than (S)-(-)-64 (ED25 > 1.5 mg/kg/d) or pioglitazone (ED25 = 6 mg/kg/d) in KKAy mice. It also exhibited a 10-fold more potent antidiabetic activity (ED25 = 0.05 mg/kg/d) than pioglitazone (ED25 = 0.5 mg/kg/d) in Wistar fatty rats. The antidiabetic effects of this compound are considered to be due to its potent agonistic activity for peroxisome proliferator-activated receptor γ (EC50 = 8.87 nM).

Thiazolidinedione derivatives, their production and use

A 2,4-thiazolidinedione derivative of the formula (I): STR1 wherein R is an optionally substituted hydrocarbon group or heterocyclic group which may be attached through a hydrocarbon chain; n is 0 or 1; X is CH or N; Y is a bivalent hydrocarbon group; Rs

Oxazolidinedione derivatives and their use

Novel 2,4-oxazolidinedione compounds of the formula: STR1 wherein R is a hydrocarbon residue or a heterocyclic group each of which may be substituted; Y is --CO--, --CH(OH)-- or --NR3 -- (wherein R3 is an alkyl group which may be substituted); m is 0 or 1; n is 0, 1 or 2; X is CH or N; A is bivalent straight or branched hydrocarbon chain residue having 1 to 7 carbon atoms; R1 and R2 each are hydrogen or an alkyl group, or R1 and R2 are combined with each other to form a 5- to 6-membered heterocyclic group optionally containing nitrogen; L and M each are hydrogen, or L and M are combined with each other to form a bond, or pharmaceutically acceptable salts thereof, having excellent hypoglycemic and hypolipidemic activities and are useful as anti-diabetics or hypolipidemic agents.